Health

Anvisa launched the inclusion of 5,000 volunteers in test

[ad_1] The National Health Surveillance Agency (Anvisa) today authorized AstraZeneca to test its possible vaccine against covid-19 in more than 5,000 volunteers in Brazil in the framework of Phase 3 clinical trials carried out in the country, reported the Federal University of São Paulo (Unifesp), which coordinates studies in the …

Read More »